Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis.

CONCLUSIONS: These data suggest that the efficacy of isavuconazole for treatment of IA is superior to AmB-D and comparable with both L-AmB and voriconazole. PMID: 30022696 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30022696?dopt=Abstract

Source: Current Medical Research and Opinion - July 21, 2018 Category: Research Tags: Curr Med Res Opin Source Type: research